Columbia Colon Cancer Prevention Program (C3P2)

Division of Digestive & Liver Diseases, Harold Frucht, M.D.

Colon cancer is the second leading cause of death resulting from malignancy in both men and women. Each American has a 6% cumulative lifetime risk of colon cancer, and 40% of these individuals will succumb to the disease. Most cancers are of the sporadic type and develop in common pre-malignant polyps. Approximately 25% of colon cancers are either inherited or familial. These cancers have biological behavior that differs markedly from the sporadic type colon cancers and require more intensive screening strategies.

Much has been accomplished to facilitate the prevention, screening, and early detection of colon cancer. At present, colon cancer risk is assessed by the evaluation of clinical factors and by inherited factors that are possible to detect by molecular biological techniques. The Columbia Colon Cancer Prevention Program stratifies each individual’s risk for colon cancer and recommends appropriate screening.

Eligible individuals would include:

§ Age >50

§ Age >40 with family history of colon polyps/colon cancer

§ Positive FOBT

** This program will be limited to colon cancer screening, or syndromic gastrointestinal cancer. Assorted other medical issues will be referred back to the primary practitioner. Dr. Frucht is able to see patients whose insurance coverage is with Affinity, Community Premier Plus and Medicare, as well as selected other commercial plans.

Preferred pre-procedure testing

(If bloodwork or EKG has been performed, the patient should bring the results with them or testing can be ordered by the GI physician, as needed, on the day of service at the

Herbert Irving Pavilion)

§ CBC/PT & PTT/ Basic Metabolic Panel/EKG

For all questions and referrals, please contact:

Eileen Farrell

Columbia University Medical Center

Herbert Irving Pavilion

161 Fort Washington Avenue, Suite 301

New York, NY 10032

Tel: 212-305-5333

Fax: 212-305-5576